ACHIEVE LIFE SCIENCES, INC. - ACHV

Ownership (Schedule 13D / 13G) · latest 50 filings · Back to all files
Visible: 0
Filed Form Reporting person Percent Shares SEC
Aug 17, 2026 SCHEDULE 13G Logos Global Management LP 9.99% 10,538,440 View
Aug 17, 2026 SCHEDULE 13G Logos Global Management GP LLC 9.99% 10,538,440 View
Aug 17, 2026 SCHEDULE 13G Logos Global Master Fund LP 5.1% 5,200,000 View
Aug 17, 2026 SCHEDULE 13G Logos GP LLC 5.1% 5,200,000 View
Aug 17, 2026 SCHEDULE 13G Logos Opportunities Fund V LP 5.0% 5,338,440 View
Aug 17, 2026 SCHEDULE 13G Logos Opportunities V GP LLC 5.0% 5,338,440 View
Aug 17, 2026 SCHEDULE 13G Arsani William 9.99% 10,538,440 View
Aug 17, 2026 SCHEDULE 13G Graham Walmsley 5.0% 5,338,440 View
Aug 13, 2026 SCHEDULE 13G JANUS HENDERSON GROUP Ltd. 5.4% 5,502,064 View
Jul 28, 2026 SCHEDULE 13G/A Franklin Resources, Inc. 8.3% 8,878,942 View
Jul 28, 2026 SCHEDULE 13G/A Charles B. Johnson 0.0% 0 View
Jul 28, 2026 SCHEDULE 13G/A Rupert H. Johnson, Jr. 0.0% 0 View
Jul 28, 2026 SCHEDULE 13G/A Franklin Advisers, Inc. 8.3% 8,878,942 View
Jul 27, 2026 SCHEDULE 13G BlackRock, Inc. 5.1% 5,271,391 View
Jul 08, 2026 SCHEDULE 13G Vivo Opportunity Fund Holdings, L.P. 1.8% 1,944,430 View
Jul 08, 2026 SCHEDULE 13G Vivo Opportunity Co-Invest, L.P. 1.2% 1,220,358 View
Jul 08, 2026 SCHEDULE 13G Vivo Opportunity Co-Invest (Cycle 3), L.P. 2.0% 2,140,852 View
Jul 08, 2026 SCHEDULE 13G Vivo Opportunity, LLC 5.0% 5,305,640 View
Jul 08, 2026 SCHEDULE 13G Vivo Opportunity Cayman Fund, L.P. 0.2% 196,424 View
Jul 08, 2026 SCHEDULE 13G Vivo Opportunity Cayman, LLC 0.2% 196,424 View
May 07, 2026 SCHEDULE 13G/A Franklin Resources, Inc. 6.2% 6,369,252 View
May 07, 2026 SCHEDULE 13G/A Charles B. Johnson 0.0% 0 View
May 07, 2026 SCHEDULE 13G/A Rupert H. Johnson, Jr. 0.0% 0 View
May 07, 2026 SCHEDULE 13G/A Franklin Advisers, Inc. 6.2% 6,369,252 View
Apr 27, 2026 SCHEDULE 13D — 4.99% 1,700 View
Apr 24, 2026 SCHEDULE 13G Paradigm BioCapital Advisors LP 9.2% 9,903,712 View
Apr 24, 2026 SCHEDULE 13G Paradigm BioCapital Advisors GP LLC 9.2% 9,903,712 View
Apr 24, 2026 SCHEDULE 13G Senai Asefaw, M.D. 9.2% 9,903,712 View
Apr 24, 2026 SCHEDULE 13G Paradigm BioCapital International Fund Ltd. 8.1% 8,687,536 View
Apr 24, 2026 SCHEDULE 13D — 100.0% — View
Apr 24, 2026 SCHEDULE 13G Frazier Life Sciences Public Fund, L.P. 6.5% 6,625,788 View
Apr 24, 2026 SCHEDULE 13G FHMLSP, L.P. 6.5% 6,625,788 View
Apr 24, 2026 SCHEDULE 13G FHMLSP, L.L.C. 6.5% 6,625,788 View
Apr 24, 2026 SCHEDULE 13G Frazier Life Sciences XI, L.P. 0.1% 61,958 View
Apr 24, 2026 SCHEDULE 13G FHMLS XI, L.P. 0.1% 61,958 View
Apr 24, 2026 SCHEDULE 13G FHMLS XI, L.L.C. 0.1% 61,958 View
Apr 24, 2026 SCHEDULE 13G Frazier Life Sciences XII, L.P. 0.8% 777,090 View
Apr 24, 2026 SCHEDULE 13G FHMLS XII, L.P. 0.8% 777,090 View
Apr 24, 2026 SCHEDULE 13G FHMLS XII, L.L.C. 0.8% 777,090 View
Apr 24, 2026 SCHEDULE 13G Venrock Healthcare Capital Partners III, L.P. 5.2% 5,502,064 View
Apr 24, 2026 SCHEDULE 13G VHCP Co-Investment Holdings III, LLC 5.2% 5,502,064 View
Apr 24, 2026 SCHEDULE 13G Venrock Healthcare Capital Partners EG, L.P. 5.2% 5,502,064 View
Apr 24, 2026 SCHEDULE 13G VHCP Management III, LLC 5.2% 5,502,064 View
Apr 24, 2026 SCHEDULE 13G VHCP Management EG, LLC 5.2% 5,502,064 View
Apr 24, 2026 SCHEDULE 13G Nimish Shah 5.2% 5,502,064 View
Apr 24, 2026 SCHEDULE 13G Bong Y. Koh 5.2% 5,502,064 View
Percent = "% of class represented by amount beneficially owned" for this reporting person in the filed 13D/13G. Shares = reported beneficial ownership amount for the same row (not portfolio shares from 13F). Amendments (/A) can repeat the same holder over time, so rows should not be summed. Extraction is best-effort from filing text and can be missing or noisy; verify exact figures via the SEC link in each row.